Increased NF-κB activity in CTCL is also responsible for increased resistance to apoptosis by up-regulating the anti-apoptotic cellular inhibitor of apoptosis proteins (cIAP) and BCL-2 [22]. This evidence concerns the gene NFKB1 and primary cutaneous T-cell non-Hodgkin lymphoma.